drugset / Trial / NCT04830449
Clinical Efficacy and Safety Evaluation of HCP1904-2 in Essential Hypertension Patients
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to evaluate of efficacy and safety of HCP1904-2 and RLD2001-2 alone in patients with essential hypertension inadequately controlled on RLD2001-2 monotherapy.
Timeline
- Start
- 2020-10-29
- Primary completion
- 2021-08-24
- Completion
- 2021-08-24
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HCP1904-2 | Unknown | — | Oral |
| Comparator | RLD2001-2 | Unknown | — | Oral |